A detailed history of Mml Investors Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mml Investors Services, LLC holds 313,688 shares of BMY stock, worth $18.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
313,688
Previous 309,134 1.47%
Holding current value
$18.1 Million
Previous $12.8 Million 26.42%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $180,611 - $235,669
4,554 Added 1.47%
313,688 $16.2 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $3.28 Million - $4.31 Million
-81,414 Reduced 20.85%
309,134 $12.8 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $4.34 Million - $4.92 Million
90,386 Added 30.11%
390,548 $21.2 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $3.43 Million - $4.09 Million
-70,752 Reduced 19.08%
300,162 $15.4 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $3.73 Million - $4.17 Million
-64,494 Reduced 14.81%
370,914 $21.5 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $1.07 Million - $1.18 Million
16,717 Added 3.99%
435,408 $27.8 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $650,594 - $737,921
9,901 Added 2.42%
418,691 $29 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $1.46 Million - $1.73 Million
21,331 Added 5.51%
408,790 $29.4 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2,785 - $1.65 Million
-21,427 Reduced 5.24%
387,459 $27.5 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $290,552 - $319,999
-4,001 Reduced 0.97%
408,886 $31.5 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $6.32 Million - $7.58 Million
102,867 Added 33.18%
412,887 $30.2 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $5.96 Million - $6.95 Million
-111,148 Reduced 26.39%
310,020 $19.3 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $3.39 Million - $3.97 Million
57,325 Added 15.76%
421,168 $24.9 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $1.09 Million - $1.19 Million
17,651 Added 5.1%
363,843 $24.3 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $2.69 Million - $3.03 Million
45,380 Added 15.09%
346,192 $21.9 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $1.92 Million - $2.17 Million
33,179 Added 12.4%
300,812 $18.7 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $4.45 Million - $4.93 Million
77,537 Added 40.79%
267,633 $16.1 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $2.35 Million - $2.75 Million
42,931 Added 29.17%
190,096 $11.2 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $1.07 Million - $1.55 Million
23,037 Added 18.56%
147,165 $8.2 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $1.36 Million - $1.77 Million
27,608 Added 28.6%
124,128 $7.97 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $2.37 Million - $2.8 Million
-55,296 Reduced 36.42%
96,520 $4.9 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $461,638 - $510,471
10,346 Added 7.31%
151,816 $6.89 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $8,798 - $10,491
-195 Reduced 0.14%
141,470 $6.75 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $2.74 Million - $3.55 Million
56,128 Added 65.62%
141,665 $7.36 Million
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $1.1 Million - $1.24 Million
19,898 Added 30.31%
85,537 $5.31 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $117,583 - $146,554
-2,327 Reduced 3.42%
65,639 $3.63 Million
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $840,977 - $968,134
-14,035 Reduced 17.12%
67,966 $4.3 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $1.46 Million - $1.59 Million
-24,368 Reduced 22.91%
82,001 $5.03 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $5.87 Million - $6.78 Million
106,369
106,369 $6.78 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.